NASDAQ:ENZY (ENZY) (ENZY) Stock Price, News & Analysis → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free ENZY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$11.85▼$11.8550-Day Range N/A52-Week Range$6.30▼$12.35VolumeN/AAverage Volume120,557 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ENZY) alerts: Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About (ENZY) Stock (NASDAQ:ENZY)Enzymotec Ltd. is a nutritional ingredients and medical foods company. The Company's technologies, research expertise and clinical validation process enables it to develop solutions across a range of products. The Company operates in two segments: Nutrition segment and VAYA Pharma segment. Both of the Company's segments offer a range of products that leverage its lipid-related offerings. Its product suite addresses the entire human life-cycle, from infancy to old age, and comprises ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor's supervision. It markets its product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. The Company's clinically-validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases.Read More Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. ENZY Stock News HeadlinesMay 6, 2024 | markets.businessinsider.comCalliditas Announces Positive Data From Proof-of-concept Phase 2 Trial With SetanaxibApril 25, 2024 | finanznachrichten.deEnzymatica AB: Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunitiesMarch 27, 2024 | finance.yahoo.comNotice of Annual General Meeting 2024 in Enzymatica AB (publ)March 13, 2024 | msn.comEnzymatica wins CE-certification for nasal spray ColdZymeMarch 4, 2024 | msn.com32 top US cities to have a catFebruary 12, 2024 | msn.comNovo Nordisk’s parent eyes $7B annual investments by 2030: FTJanuary 10, 2024 | msn.comCo, gdzie, kiedy? Wydarzenia kulturalne i imprezy w Słupsku na ten tydzieńJanuary 2, 2024 | msn.comEarthquake Jolts Japan, No Indonesian Citizens Become VictimsDecember 18, 2023 | msn.com'Hello Ghost' | Air date, plot, cast and is the Netflix movie worth watchingNovember 29, 2023 | afr.comCourt blocks telehealth consultations for euthanasiaOctober 27, 2023 | yahoo.comHello Ghost: Where to Watch & Stream OnlineOctober 25, 2023 | theglobeandmail.comMyProtein Discount Codes October 2023September 25, 2023 | finance.yahoo.comGlobal Bromelain Market is Anticipated to Reach US$ 1.15 Billion by 2031, Registering a 4.5% CAGR: TMR ReportAugust 4, 2023 | msn.com2 Men Allegedly Stole Roughly $9 Million in Jewelry, Cash from Russian Family at Barcelona AirportAugust 4, 2023 | msn.comTinder will soon let AI pick your dating profile photos for youJuly 26, 2023 | msn.comTrump records video encouraging Republicans to vote earlyMay 25, 2023 | msn.comHow To Nail The Bare Skin MovementMay 1, 2023 | msn.com59-year-old man charged in December cutting death of one man, wounding of anotherApril 5, 2023 | finanznachrichten.deEnzymatica AB: Enzymatica publishes annual report for 2022March 31, 2023 | finance.yahoo.comNotice of Annual General Meeting 2023 in Enzymatica AB (publ)March 29, 2023 | msn.comLyceum Lady Pirates, wagi kontra sa Perpetual Lady Altas sa NCAA 98 Women's Volleyball Tournament Semifinals | UBMarch 15, 2023 | msn.com15-year-old reported missing in Shelby CountyMarch 5, 2023 | msn.comCops arrested over robbery, stolen police gun recovered from slain suspectMarch 5, 2023 | msn.comApple iPhone 14, 14 Plus might soon come in this fresh and vibrant colour optionJanuary 18, 2023 | reuters.comENZY.ST - | Stock Price & Latest News | ReutersSee More Headlines Receive ENZY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ENZY) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/17/2017Today6/01/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ENZY CUSIPN/A CIK1578809 Webwww.enzymotec.com Phone+972-7-47177177FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesSteve Dubin (Age 60)Independent Chairman of the Board Erez Israeli (Age 48)President, Chief Executive Officer Yoav Doppelt (Age 48)Independent Vice Chairman of the Board Dror Israel (Age 46)Chief Financial Officer, Vice President Yoav Kahane (Age 42)Chairman of Advanced Lipids AB Yoni Twito (Age 47)Chief Operating Officer Naama Zamir (Age 43)Vice President - Human Resources and Information Systems Gai Ben-Dror (Age 45)Vice President - Process Development Tzafra Cohen (Age 47)Vice President - Research & Development Tamar D. Howson (Age 68)Director More Executives ENZY Stock Analysis - Frequently Asked Questions How were (ENZY)'s earnings last quarter? (ENZY) (NASDAQ:ENZY) posted its quarterly earnings data on Wednesday, May, 17th. The biotechnology company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.06 by $0.03. The biotechnology company earned $12 million during the quarter, compared to analysts' expectations of $14.23 million. The business's revenue was down 14.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.09 earnings per share. What other stocks do shareholders of (ENZY) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ENZY) investors own include Caesarstone (CSTE), Laredo Petroleum (LPI), Allena Pharmaceuticals (ALNA), Baidu (BIDU), Camtek (CAMT), Telaria (TLRA), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB) and Aquinox Pharmaceuticals (AQXP). This page (NASDAQ:ENZY) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ENZY) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
